Armistice Capital Master Fund Ltd., 10% Owner at ReShape Lifesciences Inc. (RSLS), bought 2,400 shares at $3.58 ($9K) on 2020-11-10, disclosed to the SEC on 2020-11-12.
Open-market purchase of $9k RSLS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| AVTX | BUY | 2022-01-11 | $1.1M | — | Filing → |
| AYTU | BUY | 2020-12-15 | $8.0M | — | Filing → |
| CERC | BUY | 2020-12-07 | $49K | — | Filing → |